S M Cockfield

Summary

Affiliation: University of Alberta
Country: Canada

Publications

  1. ncbi Identifying the patient at risk for post-transplant lymphoproliferative disorder
    S M Cockfield
    Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Canada
    Transpl Infect Dis 3:70-8. 2001
  2. ncbi Serologic responses to hepatitis C virus in solid organ transplant recipients
    J K Preiksaitis
    Medical Microbiology and Public Health, University of Alberta Hospitals, Edmonton, Canada
    Transplantation 64:1775-80. 1997
  3. ncbi Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause
    B Sis
    Laboratory Medicine and Pathology, and Medicine, Division of Nephrology and Transplantation Immunology, University of Alberta, Edmonton, AB, Canada
    Am J Transplant 7:1743-52. 2007

Collaborators

Detail Information

Publications3

  1. ncbi Identifying the patient at risk for post-transplant lymphoproliferative disorder
    S M Cockfield
    Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Canada
    Transpl Infect Dis 3:70-8. 2001
    ..It is hoped that implementation of such strategies will render early PTLD a preventable complication of transplantation...
  2. ncbi Serologic responses to hepatitis C virus in solid organ transplant recipients
    J K Preiksaitis
    Medical Microbiology and Public Health, University of Alberta Hospitals, Edmonton, Canada
    Transplantation 64:1775-80. 1997
    ..We sought to determine the historical incidence of donor- and transfusion-acquired HCV infection in kidney transplant (RTx) and heart transplant (HTx) recipients at our center and to study the kinetics of seroconversion to HCV...
  3. ncbi Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause
    B Sis
    Laboratory Medicine and Pathology, and Medicine, Division of Nephrology and Transplantation Immunology, University of Alberta, Edmonton, AB, Canada
    Am J Transplant 7:1743-52. 2007
    ..The remaining 27%, mostly BD, may be a different disease or a stage in which A and C are undetectable...